Health Advisory: New COVID-19 vaccines authorized; bivalent COVID-19 vaccines deauthorized

Kitsap County Washington sent this bulletin at 09/20/2023 04:02 PM PDT

Sept. 20, 2023

Health Advisory: New COVID-19 vaccines authorized, previous bivalent COVID-19 vaccines deauthorized

ACTIONS REQUESTED

BE AWARE that on Sept. 11, 2023, the FDA approved and/or authorized new, updated "2023–2024" COVID-19 vaccines from Moderna and Pfizer. On Sept. 12, 2023, the CDC and CDC Advisory Panel on Immunization Practices (ACIP) recommended everyone 6 months or older get a new 2023–2024 COVID-19 vaccine.

The CDC's 2023–2024 COVID-19 vaccine recommendations are as follows:

Unvaccinated children 6 months to 4 years old should get a multidose initial series (2 doses of Moderna or 3 doses of Pfizer).
Previously vaccinated children 6 months to 4 years old should get 1 or 2 doses (timing and number of doses depends on previous COVID-19 vaccine received).
Regardless of previous vaccination, people 5 years or older should get 1 dose at least 2 months after their last dose of any COVID-19 vaccine.

BE AWARE that the FDA deauthorized previous bivalent COVID-19 vaccines from Moderna and Pfizer. CDC’s Novavax recommendations remain unchanged (see the Background section for details).

REPORT unused bivalent COVID-19 vaccine as wastage and update your inventory in WAIIS.

Indicate “Expired” in category and reason as “Expired Opened Multi-dose Vials.”

DISPOSE of deauthorized vaccine according to local medical waste guidelines.

BE AWARE that the federal government will no longer provide COVID-19 vaccine.

Providers can get COVID-19 vaccine through:
- Childhood Vaccine Program
- Adult Vaccine Program
- Bridge Access Program
- Commercial marketplace

BACKGROUND

Vaccination remains the best way to prevent COVID-19 hospitalization and death and reduces the risk of long COVID. The new, updated 2023–2024 COVID-19 vaccines better protect against circulating strains of the virus. The vaccines remain safe and effective with rare serious side effects.

CDC will soon update its Interim Clinical Considerations for Use of COVID-19 Vaccines to provide additional guidance for clinicians. Co-administration of updated 2023-2024 COVID-19 vaccines is acceptable, but providers should help patients determine if they should get multiple vaccines at once or stagger them.

Most people can receive updated 2023-2024 COVID-19 vaccines at no cost.

Children 6 months–18 years old can get updated 2023-2024 COVID-19 vaccines at no cost from providers in the Childhood Vaccine Program.
Adults without health insurance can get updated (2023-2024) COVID-19 vaccines at no cost from providers in the Adult Vaccine Program and Bridge Access Program.
- In coming weeks, vaccines.gov will have an updated list of everywhere COVID-19 vaccine is available from the Bridge Access Program.
Most health insurance will cover updated 2023-2024 COVID-19 vaccines for adults.

Novavax

Novavax COVID-19 vaccine remains authorized and available in the United States for people:

12 years or older as a primary series.
18 years or older as a first booster.

FDA is evaluating an updated version of the vaccine. It may become available in coming weeks.

ADDITIONAL RESOURCES

CDC's press release on fall/winter COVID-19 vaccine recommendations
CDC's guide on how to stay up to date with COVID-19 vaccines
Washington State Department of Health's COVID-19 vaccine information page
Kitsap Public Health's recent respiratory illness season bulletin

This advisory is also posted on the health advisory page of our Provider Resources website, providers.kitsappublichealth.org.

Contact us:

Email or call 360-728-2235

Stay connected with Kitsap Public Health:

Manage your subscriptions:
Manage Preferences | Unsubscribe | Delete Profile | Help